Stay updated on Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T06:48:16.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.2 to v3.1.0 and added new contact phone numbers: (240) 760-6050, (240) 760-6057, and 888-624-1937.
    Difference
    0.1%
    Check dated 2025-09-28T03:16:29.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Updated to Revision v3.0.2 from v3.0.1; the Back to Top link was removed.
    Difference
    0.2%
    Check dated 2025-09-13T17:39:19.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T15:24:16.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, as well as new content related to blood proteins and immunology. Notably, the last update date has changed to August 27, 2025.
    Difference
    4%
    Check dated 2025-08-30T12:07:09.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:42:55.000Z thumbnail image

Stay in the know with updates to Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.